Doctor of Osteopathy Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Kenneth Trimmer

Interventional Cardiology Saint Louis, MO Doctor of Osteopathy

NPI 1124060975 CMS profile 5125

3023 N Ballas Rd Ste 200D, Saint Louis, MO 63131

Open in the dashboard

General payments

$11,670

339 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Kenneth Trimmer of Saint Louis, MO is reported in the CMS Open Payments database as having received $11,670 across 339 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 62nd percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $156 1
2023 General $1,396 33
2022 General $2,958 81
2021 General $1,729 65
2020 General $1,373 44
2019 General $4,059 115

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kenneth Trimmer
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Kenneth Trimmer were reported at $0. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Kenneth Trimmer Interventional Cardiology median Middle half National median
2019 $4,059 $1,097 $329–$3,048 $163
2020 $1,373 $473 $161–$1,480 $114
2021 $1,729 $677 $233–$1,827 $132
2022 $2,958 $978 $333–$2,724 $149
2023 $1,396 $1,136 $382–$2,986 $160
2024 $156 $1,181 $395–$3,326 $164
2025 $0 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Abbott Laboratories $2,358 94 payments
  2. E.R. Squibb & Sons, L.L.C. $997 48 payments
  3. Medtronic, Inc. $927 14 payments
  4. Penumbra, Inc. $879 6 payments
  5. Abiomed $815 8 payments
  6. Medtronic Vascular, Inc. $729 9 payments
  7. Amgen Inc. $728 24 payments
  8. Cardiovascular Systems Inc. $604 12 payments
  9. Edwards Lifesciences Corporation $567 5 payments
  10. Boston Scientific Corporation $507 5 payments
  11. Other $2,558 114 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $11,310 337 payments
  2. Travel and Lodging $220 1 payment
  3. Grant $140 1 payment
Products named General payments · program years 2019–2024
  1. Indigo $902 7 payments
  2. Impella $815 8 payments
  3. ELIQUIS Cardiovascular $732 42 payments
  4. Repatha $728 24 payments
  5. GALLANT $477 14 payments
  6. ELIQUIS Cardiovascular;Metabolic Disease $462 35 payments
  7. CoreValve Evolut Transcatheter Valve Systems $461 3 payments
  8. ENTRESTO $457 18 payments
  9. CoreValve Evolut Transcatheter Valve Systems $456 5 payments
  10. Diamondback Coronary $378 4 payments
  11. Other $7,603 242 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

339 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record